Ipamorelin

GH/GHRH Research Compound

Growth hormone releasing peptide (GHRP)

Mechanism of Action

Stimulates ghrelin receptors to release growth hormone. Considered one of the mildest GHRPs with fewer side effects.

Ipamorelin is a research compound (not FDA-approved) that stimulates ghrelin receptors to promote growth hormone release. Self-reported data from 112 individuals across 253 reports suggests dominant areas of interest are body composition (40.2%) and sleep quality (24.1%) — outpacing direct GH elevation (21.4%) as a primary focus.

253
Community Posts
112
Users Discussing
1
Research Articles
0

Reported Outcomes

Clinical grade reflects published research; Community grade reflects user reports (n=253).

Body Composition

Changes in muscle vs fat ratio

Clinical: D
Community: B
40% (61)
Sleep Quality

Effects on sleep quality

Clinical: D
Community: B
24% (42)
Growth Hormone

Effects on growth hormone levels

Clinical: D
Community: B
21% (41)
Mental/Mood

Effects on mood and cognitive function

Clinical: D
Community: B
13% (20)
Energy Levels

Changes in energy and fatigue levels

Clinical: D
Community: A
11% (14)
Muscle Repair

Muscle recovery and repair from exercise or injury

Clinical: D
Community: C
4% (5)

Who Discusses Ipamorelin

From community reports with demographic data.

Gender

Male 78%
Female 22%

n=55

Age Distribution

49
median age
range: 26-63
<30
30s
40s
50s
60+

n=20

Side Effects

Limited data

Based on 7 user reports (n=7). Frequency indicates how often each was mentioned.

Common (>5%)

Insomnia
Mild 2 reports 15.4%

Uncommon (1-5%)

Drenching Night Sweats
Mild 1 reports 7.7%
Tingling Issue
Mild 1 reports 7.7%
Injection Site Reaction (Isr)
Mild 1 reports 7.7%
Pain
Mild 1 reports 7.7%
High Estrogen
Mild 1 reports 7.7%
Post Injection Pain (Pip)
Mild 1 reports 7.7%
Bump And Redness At Injection Site
Mild 1 reports 7.7%

Risks & Warnings

Important safety considerations based on clinical data and community reports.

!

Psychiatric Effects

4 mentions

Monitor for mood changes. Report any concerning psychiatric symptoms to healthcare provider.

i

Water Retention

16 mentions

Fluid retention can occur with GH-releasing peptides. Usually mild and temporary.

i

Injection Site Reactions

7 mentions

Local reactions are common and usually mild. Rotate injection sites.

Dosing

Standard Protocol

Starting Dose
100-300mcg 2-3x daily
Titration
No established protocol
Half-life
~2 hours
Administration
Subcutaneous injection

Community Dosing Patterns

Based on 97 mentions

Community-reported patterns, not medical advice.

250mcg daily
4
200mcg daily
3
100mcg daily
3
daily
2
5 days on/2 days off
2

Pricing

Research-grade reference pricing for 10mg vial. Prices vary by vendor and quantity. Research chemicals require self-mixing and lack medical oversight. Shipping is not included.

We do not list vendors. Prices are aggregated from community reports and should be treated as rough ranges.

US Research Grade

$70

Single small vial from US domestic vendors

US Research (Bulk)

$39.2

Per-dose equivalent when buying larger US vials

China Research

$6

Per-vial when buying 10-pack from Chinese vendors

Research

1
Total Articles
0 0

Key Studies

Attenuation of Visceral and Somatic Nociception by Ghrelin Mimetics Preclinical

J Exp Pharmacol (2020)

Commonly Stacked With

Based on 253 community posts mentioning Ipamorelin.

Tesamorelin 93 mentions (36.8%)
CJC-1295 52 mentions (20.6%)
Retatrutide 33 mentions (13%)
Tirzepatide 21 mentions (8.3%)
TB-500 20 mentions (7.9%)

Switching Patterns

Based on 24 discussions about switching to or from Ipamorelin.

→ Switching FROM

Retatrutide 6 mentions

Users who switched to Ipamorelin

← Switching TO

Retatrutide 4 mentions

Users who switched from Ipamorelin